Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where therapy possibilities remain limited. Utilize the links below to learn much more about our portfolio of cytokine-based imm